Skip to main content
Erschienen in: Journal of Clinical Immunology 2/2010

01.03.2010

Leukocyte Adhesion Deficiency Type II: Long-Term Follow-Up and Review of the Literature

verfasst von: Yael Gazit, Adi Mory, Amos Etzioni, Moshe Frydman, Oded Scheuerman, Ruth Gershoni-Baruch, Ben-Zion Garty

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Leukocyte adhesion deficiency (LAD) is a group of rare inherited disorders characterized by immune deficiency and peripheral neutrophilia. There are only seven reported cases of LAD type II worldwide, and no long-term follow-up data.

Case Report

We reviewed the medical file of a 20-year-old man with LAD II. Clinical characteristics included short stature, severe mental retardation, and autistic features. He had had no severe infections since infancy, and his current immunological status was stable. The last laboratory work-up revealed mild leukocytosis and neutrophilia. Genetic analysis of the Golgi GDP-fucose transporter (GFTP) sequence yielded a point mutation resulting in Y337C amino acid transition in the tenth transmembrane domain.

Conclusion

In conclusion, in LAD II, the main clinical countenance shifts from frequent infections due to immunodeficiency in the early years to the metabolic consequences of the defect in fucose metabolism, i.e., retarded growth and mental retardation, in the later years. A novel mutation in the GFTP loci associated with LAD II is described.
Literatur
1.
Zurück zum Zitat Anderson DC, Smith CW. Leukocyte adhesion deficiencies. In: Scriver C, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. p. 4829–56. Anderson DC, Smith CW. Leukocyte adhesion deficiencies. In: Scriver C, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. p. 4829–56.
2.
Zurück zum Zitat Bauer TR, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vector. Nat Med. 2008;14:93–7.CrossRefPubMed Bauer TR, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vector. Nat Med. 2008;14:93–7.CrossRefPubMed
3.
Zurück zum Zitat Yakubenia S, Wild MK. Leukocyte adhesion deficiency II advances and open questions. FEBS J. 2006;273:4390–8.CrossRefPubMed Yakubenia S, Wild MK. Leukocyte adhesion deficiency II advances and open questions. FEBS J. 2006;273:4390–8.CrossRefPubMed
4.
Zurück zum Zitat Marquardt T, Lühn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood. 1999;94:3976–85.PubMed Marquardt T, Lühn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood. 1999;94:3976–85.PubMed
5.
Zurück zum Zitat Etzioni A, Tonetti M, Vestweber D, Marquardt T. Fucose supplementation in leukocyte adhesion deficiency type II. Blood. 2000;95:3641–3.PubMed Etzioni A, Tonetti M, Vestweber D, Marquardt T. Fucose supplementation in leukocyte adhesion deficiency type II. Blood. 2000;95:3641–3.PubMed
6.
Zurück zum Zitat Alon R, Etioni A. LAD III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 2003;24:561–6.CrossRefPubMed Alon R, Etioni A. LAD III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 2003;24:561–6.CrossRefPubMed
7.
Zurück zum Zitat Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhon GI, Gershoni-Baruch R. Kindlin-3: a new gene involved in the pathogenesis of LAD III. Blood. 2008;112:2591.CrossRefPubMed Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhon GI, Gershoni-Baruch R. Kindlin-3: a new gene involved in the pathogenesis of LAD III. Blood. 2008;112:2591.CrossRefPubMed
8.
Zurück zum Zitat Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, et al. Leukocyte adhesion deficiency III is caused by mutations in Kindlin3 affecting integrin activation. Nat Med. 2009;15:306–12.CrossRefPubMed Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, et al. Leukocyte adhesion deficiency III is caused by mutations in Kindlin3 affecting integrin activation. Nat Med. 2009;15:306–12.CrossRefPubMed
9.
Zurück zum Zitat Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JR, et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med. 1992;327(25):1789–92.PubMedCrossRef Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JR, et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med. 1992;327(25):1789–92.PubMedCrossRef
10.
Zurück zum Zitat Frydman M, Etzioni A, Eidlitz-Markus T, Avidor I, Varsano I, Shechter Y, et al. Rambam–Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype. Am J Med Genet. 1992;44:297–302.CrossRefPubMed Frydman M, Etzioni A, Eidlitz-Markus T, Avidor I, Varsano I, Shechter Y, et al. Rambam–Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype. Am J Med Genet. 1992;44:297–302.CrossRefPubMed
11.
Zurück zum Zitat Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni-Baruch R, Berninsone PM, et al. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG)IIc founder effect and genotype/phenotype correlation. Am J Med Genet. 2002;110:131–5.CrossRefPubMed Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni-Baruch R, Berninsone PM, et al. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG)IIc founder effect and genotype/phenotype correlation. Am J Med Genet. 2002;110:131–5.CrossRefPubMed
12.
Zurück zum Zitat Marquardt T, Brune T, Lühn K, Zimmer KP, Korner C, Fahntz L, et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr. 1999;134:681–8.CrossRefPubMed Marquardt T, Brune T, Lühn K, Zimmer KP, Korner C, Fahntz L, et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr. 1999;134:681–8.CrossRefPubMed
13.
Zurück zum Zitat Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood. 2003;101:1705–12.CrossRefPubMed Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood. 2003;101:1705–12.CrossRefPubMed
14.
Zurück zum Zitat Helmus Y, Denecke J, Yakubenia S, Robinson P, Luhn K, Watson DL, et al. Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood. 2006;107:3959–66.CrossRefPubMed Helmus Y, Denecke J, Yakubenia S, Robinson P, Luhn K, Watson DL, et al. Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood. 2006;107:3959–66.CrossRefPubMed
15.
Zurück zum Zitat Etzioni A, Gershoni-Baruch R, Pollack S, Shehadeh N. Leukocyte adhesion deficiency type II: long-term follow-up. J Allergy Clin Immunol. 1998;102:323–4.CrossRefPubMed Etzioni A, Gershoni-Baruch R, Pollack S, Shehadeh N. Leukocyte adhesion deficiency type II: long-term follow-up. J Allergy Clin Immunol. 1998;102:323–4.CrossRefPubMed
16.
Zurück zum Zitat Frydman M, Vardimon D, Shalev E, Orlin JB. Prenatal diagnosis of Rambam–Hasharon syndrome. Prenat Diagn. 1996;16:266–9.CrossRefPubMed Frydman M, Vardimon D, Shalev E, Orlin JB. Prenatal diagnosis of Rambam–Hasharon syndrome. Prenat Diagn. 1996;16:266–9.CrossRefPubMed
17.
Zurück zum Zitat Wild MK, Lühn K, Marquardt T, Vestweber D. Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs. 2002;172:161–73.CrossRefPubMed Wild MK, Lühn K, Marquardt T, Vestweber D. Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs. 2002;172:161–73.CrossRefPubMed
18.
Zurück zum Zitat Lühn K, Marquardt T, Harm E, Vestweber D. Discontinuation of fucose therapy in LAD II causes rapid loss of selectin ligands and rise of leukocyte counts. Blood. 2001;97:330–2.CrossRefPubMed Lühn K, Marquardt T, Harm E, Vestweber D. Discontinuation of fucose therapy in LAD II causes rapid loss of selectin ligands and rise of leukocyte counts. Blood. 2001;97:330–2.CrossRefPubMed
19.
Zurück zum Zitat Sturla L, Puglielli L, Tonetti M, Berninsone P, Hirschberg CB, De Fiora A, et al. Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LAD II patients. Pediatr Res. 2001;49(4):537–42.CrossRefPubMed Sturla L, Puglielli L, Tonetti M, Berninsone P, Hirschberg CB, De Fiora A, et al. Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LAD II patients. Pediatr Res. 2001;49(4):537–42.CrossRefPubMed
20.
Zurück zum Zitat Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, et al. Carbohydrate deficient glycoprotein syndrome becomes congenital disorder of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. Glycoconj J. 1999;16:669–71.CrossRefPubMed Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, et al. Carbohydrate deficient glycoprotein syndrome becomes congenital disorder of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. Glycoconj J. 1999;16:669–71.CrossRefPubMed
21.
Zurück zum Zitat Lübke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Körner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet. 2001;28:73–6.CrossRefPubMed Lübke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Körner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet. 2001;28:73–6.CrossRefPubMed
22.
Zurück zum Zitat Lühn K, Wild MD, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet. 2001;28:69–72.CrossRefPubMed Lühn K, Wild MD, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet. 2001;28:69–72.CrossRefPubMed
Metadaten
Titel
Leukocyte Adhesion Deficiency Type II: Long-Term Follow-Up and Review of the Literature
verfasst von
Yael Gazit
Adi Mory
Amos Etzioni
Moshe Frydman
Oded Scheuerman
Ruth Gershoni-Baruch
Ben-Zion Garty
Publikationsdatum
01.03.2010
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 2/2010
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9354-0

Weitere Artikel der Ausgabe 2/2010

Journal of Clinical Immunology 2/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.